ELISA competition assays were used to assess the avidity/affinity of NAbs, and this revealed that the proportion of high-avidity/affinity anti-TDP-43 NAbs in plasma was significantly decreased in ALS. Here, TARDBP is linked to amyotrophic lateral sclerosis.